Additional Reported Adverse Effects Beyond gastroparesis and vision loss, patients have reported numerous other serious adverse effects that have led to FDA warning label updates as evidence accumulated
Some last longer, particularly after substantial weight loss of 15% or more of starting body weight
It is sold as Ozempic when used for diabetes and Wegovy when used for weight loss
Semaglutide is a medication originally developed to treat type 2 diabetes and now also FDA-approved for chronic weight management under brand names like Wegovy and Ozempic
Despite the rapid uptake of these therapies, the broader trends in who uses these drugs and the associated payments across GLP-1RA subtypes and diabetes status have not been well characterized using nationally representative US data
How much your body needs depends on several things, including body type, activity level, and environment